Lung Cancer aims to provide individuals or organisations with the most recent information on lung cancer and other thoracic malignancies. The Journal publishes original research articles, early reports, review articles and editorials on clinical and basic science aspects of topics represented by the fields of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities, outcomes). Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review. Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers. Manuscripts should be submitted online at external link http://ees.elsevier.com/lungcancer and the instructions on this site should be closely followed. Once the manuscript has been uploaded, our system automatically generates an electronic PDF proof which is then used for reviewing. All correspondence including notification of the Editor's decision and requests for revision, will be managed via this system. Authors may also track the progress of their paper using this system to final decision.